Dr. Braun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-7203Fax+1 608-263-9103
Summary
- Dr. Andrew T. Braun is a pulmonologist in Madison, WI and is affiliated with University Hospital at UW Health. He received his medical degree from University of Wisconsin School of Medicine and Public Health and completed post-graduate training at UCSF Medical Center, San Francisco and the Johns Hopkins Hospital, Baltimore. He has a masters level training in clinical investigation. He is board-certified in internal medicine, pulmonary, critical care, and sleep medicine. He is fluent in English and French. He specializes in cystic fibrosis, bronchiectatic lung disease, lung transplantation, sleep medicine, and critical care.
Education & Training
- Johns Hopkins University/Bayview Medical CenterFellowship, Sleep Medicine, 2014 - 2015
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2014
- Johns Hopkins University Bloomberg School of Public HealthMHS, Clinical Investigation, 2011 - 2012
- University of California (San Francisco)Residency, Internal Medicine, 2005 - 2008
- University of Wisconsin School of Medicine & Public HealthClass of 2005
Certifications & Licensure
- WI State Medical License 2017 - 2025
- MD State Medical License 2011 - 2018
- CA State Medical License 2007 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Publications & Presentations
PubMed
- 2 citationsVanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 a...Claire Keating, Lael M Yonker, François Vermeulen, Dario Prais, Rachel W Linnemann
The Lancet. Respiratory Medicine. 2024-12-20 - 1 citationsImpact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.Nicole Mayer-Hamblett, Alex H Gifford, Margaret Kloster, Renee Russell, Andrew T Braun
Annals of the American Thoracic Society. 2024-11-01 - 1 citationsVitamin D status and variable responses to supplements depend in part on genetic factors in adults with cystic fibrosis.Andrew T Braun, HuiChuan J Lai, Anita Laxova, Julie A Biller, Erin K Hubertz
Journal of Cystic Fibrosis. 2024-07-01
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: